Life Sciences Times, Author at Life Sciences Times

Sensory Cloud Reports Positive Phase 2a Results for SC0023 in Patients With Refractory Chronic Cough

August 20, 2025

knownwell Expands in Greater Boston, Opens Second Clinic in Woburn

August 19, 2025

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

August 15, 2025

THIS WEEK'S STORIES

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

August 13, 2025

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

August 15, 2025

Bayer Brings Popular Mexican Pain Reliever Aspirina to U.S. Market

August 15, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Qure.ai Names Dr. Javier J. Zulueta as Chief Medical Officer, Pulmonology, to Drive Lung Cancer Strategy

Enanta Pharmaceuticals Files Patent Suit Against Pfizer in European Union Court Over COVID-19 Drug Paxlovid

South Lake Pediatrics Saves Over an Hour a Day on Documentation With Sunoh.ai Integration

EliseAI Raises $250M in Series E to Expand AI Solutions in Healthcare and Housing

EDITOR PICKS

Sensory Cloud Reports Positive Phase 2a Results for SC0023 in Patients With Refractory Chronic Cough

knownwell Expands in Greater Boston, Opens Second Clinic in Woburn

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

THIS WEEK'S STORIES

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

Bayer Brings Popular Mexican Pain Reliever Aspirina to U.S. Market

POPULAR CATEGORY

ABOUT US

FOLLOW US